These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21092311)

  • 21. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
    Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
    He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EphB4 as a therapeutic target in mesothelioma.
    Liu R; Ferguson BD; Zhou Y; Naga K; Salgia R; Gill PS; Krasnoperov V
    BMC Cancer; 2013 May; 13():269. PubMed ID: 23721559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
    Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
    Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
    Crnkovic S; Rittchen S; Jandl K; Gindlhuber J; Zabini D; Mutgan AC; Valzano F; Boehm PM; Hoetzenecker K; Toller W; Veith C; Heinemann A; Schermuly RT; Olschewski A; Marsh LM; Kwapiszewska G
    Hypertension; 2023 Feb; 80(2):e17-e28. PubMed ID: 36519465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-30a regulates endothelial tip cell formation and arteriolar branching.
    Jiang Q; Lagos-Quintana M; Liu D; Shi Y; Helker C; Herzog W; le Noble F
    Hypertension; 2013 Sep; 62(3):592-8. PubMed ID: 23817492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway.
    Boardman R; Pang V; Malhi N; Lynch AP; Leach L; Benest AV; Bates DO; Machado MJC
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1065-H1075. PubMed ID: 30681366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta-like ligand 4-notch blockade and tumor radiation response.
    Liu SK; Bham SA; Fokas E; Beech J; Im J; Cho S; Harris AL; Muschel RJ
    J Natl Cancer Inst; 2011 Dec; 103(23):1778-98. PubMed ID: 22010178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
    Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
    J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
    Bhatia S; Oweida A; Lennon S; Darragh LB; Milner D; Phan AV; Mueller AC; Van Court B; Raben D; Serkova NJ; Wang XJ; Jimeno A; Clambey ET; Pasquale EB; Karam SD
    Cancer Res; 2019 May; 79(10):2722-2735. PubMed ID: 30894369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular identity of arteries, veins, and lymphatics.
    Wolf K; Hu H; Isaji T; Dardik A
    J Vasc Surg; 2019 Jan; 69(1):253-262. PubMed ID: 30154011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.
    Al Haj Zen A; Oikawa A; Bazan-Peregrino M; Meloni M; Emanueli C; Madeddu P
    Circ Res; 2010 Jul; 107(2):283-93. PubMed ID: 20508179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of tumor growth and angiogenesis by soluble EphB4.
    Martiny-Baron G; Korff T; Schaffner F; Esser N; Eggstein S; Marmé D; Augustin HG
    Neoplasia; 2004; 6(3):248-57. PubMed ID: 15153337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo.
    Jenkins DW; Ross S; Veldman-Jones M; Foltz IN; Clavette BC; Manchulenko K; Eberlein C; Kendrew J; Petteruti P; Cho S; Damschroder M; Peng L; Baker D; Smith NR; Weir HM; Blakey DC; Bedian V; Barry ST
    Mol Cancer Ther; 2012 Aug; 11(8):1650-60. PubMed ID: 22679110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling.
    Nakano T; Katsuki S; Chen M; Decano JL; Halu A; Lee LH; Pestana DVS; Kum AST; Kuromoto RK; Golden WS; Boff MS; Guimaraes GC; Higashi H; Kauffman KJ; Maejima T; Suzuki T; Iwata H; Barabási AL; Aster JC; Anderson DG; Sharma A; Singh SA; Aikawa E; Aikawa M
    Circulation; 2019 Jan; 139(1):78-96. PubMed ID: 30586693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow.
    Lobov IB; Cheung E; Wudali R; Cao J; Halasz G; Wei Y; Economides A; Lin HC; Papadopoulos N; Yancopoulos GD; Wiegand SJ
    Blood; 2011 Jun; 117(24):6728-37. PubMed ID: 21498671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
    Groppa E; Brkic S; Uccelli A; Wirth G; Korpisalo-Pirinen P; Filippova M; Dasen B; Sacchi V; Muraro MG; Trani M; Reginato S; Gianni-Barrera R; Ylä-Herttuala S; Banfi A
    EMBO Rep; 2018 May; 19(5):. PubMed ID: 29643120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial Jagged1 Antagonizes Dll4/Notch Signaling in Decidual Angiogenesis during Early Mouse Pregnancy.
    Marchetto NM; Begum S; Wu T; O'Besso V; Yarborough CC; Valero-Pacheco N; Beaulieu AM; Kitajewski JK; Shawber CJ; Douglas NC
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.